Date: 2011-11-14
Type of information: Fundraising
Company: Azellon Cell Therapeutics (UK)
Investors: IP Group (UK) - Oxford Technology Management (UK) - Hugh Osmond
Amount: £0.65 million
Funding type:
Planned used:
Others: * On November 14, 2011, Azellon Cell Therapeutics, a developer of a stem cell therapy for the repair of torn meniscal cartilage, has announced it has successfully completed a £0.65 million financing round that was required to take its pioneering stem cell bandage into human clinical trials and for related commercial activities.
Therapeutic area: Regenerative medicine